IL6 and metabolic syndrome: The patients had dyslipidemia, mild increases in HOMA-IR, circulating creatinine, inflammatory biomarkers (hs-CRP, TNF-alpha, IL-6), and indicators of fibrosis (galectin-3 and sST2).